Literature DB >> 29194868

Narrowing filtered QRS duration on signal-averaged electrocardiogram predicts outcomes in cardiac resynchronization therapy patients with nonischemic heart failure.

Atsushi Suzuki1, Tsuyoshi Shiga1, Daigo Yagishita1, Yoshimi Yagishita-Tagawa1, Kotaro Arai1, Yuji Iwanami1, Koichiro Ejima1, Kyomi Ashihara1, Morio Shoda2, Nobuhisa Hagiwara1.   

Abstract

BACKGROUND: To evaluate the impact of changes in the filtered QRS duration (fQRS) on signal-averaged electrocardiograms (SAECGs) from pre- to postimplantation on the clinical outcomes in nonischemic heart failure (HF) patients under cardiac resynchronization therapy (CRT).
METHODS: We studied 103 patients with nonischemic HF and sinus rhythm who underwent CRT implantation. SAECGs were obtained within 1 week before and 1 week after implantation and narrowing fQRS was defined as a decrease in fQRS from pre- to postimplantation. Echocardiography was performed before and 6 months after CRT implantation. The primary outcome was death from any cause. The secondary outcomes were hospitalization due to worsened HF and occurrence of ventricular tachyarrhythmias.
RESULTS: Of the 103 CRT patients, 53 (51%) showed narrowing fQRS. Left ventricular end-diastolic volume and end-systolic volume were significantly reduced (both p < .001), and the left ventricular ejection fraction was significantly increased (p < .001) after CRT in patients with narrowing fQRS, but not in patients with nonnarrowing fQRS. During a median follow-up period of 33 months, patients with narrowing fQRS exhibited better survival than patients with nonnarrowing fQRS (p = .007). A lower incidence of hospitalization due to worsened HF (p < .001) and a lower occurrence of ventricular tachyarrhythmias (p = .071) were obtained in patients with narrowing fQRS. After adjusting for confounding variables, narrowing fQRS was associated with a low risk of mortality (HR 0.27, p = .006).
CONCLUSION: Our results suggested that narrowing fQRS on SAECG after CRT implantation predicts LV reverse remodeling and long-term outcomes in nonischemic HF patients.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  QRS duration; cardiac resynchronization therapy; heart failure; mortality; signal-averaged electrocardiogram; ventricular arrhythmias

Mesh:

Year:  2017        PMID: 29194868      PMCID: PMC6931640          DOI: 10.1111/anec.12523

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  21 in total

1.  Reliability and reproducibility of QRS duration in the selection of candidates for cardiac resynchronization therapy.

Authors:  Maxime De Guillebon; Jean-Benoit Thambo; Sylvain Ploux; Antoine Deplagne; Frederic Sacher; Pierre Jais; Michel Haissaguerre; Philippe Ritter; Jacques Clementy; Pierre Bordachar
Journal:  J Cardiovasc Electrophysiol       Date:  2010-03-04

2.  Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.

Authors:  Jeff M Hsing; Kimberly A Selzman; Christophe Leclercq; Luis A Pires; Michael G McLaughlin; Scott E McRae; Brett J Peterson; Peter J Zimetbaum
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-09-28

3.  Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.

Authors:  Claudia Ypenburg; Rutger J van Bommel; C Jan Willem Borleffs; Gabe B Bleeker; Eric Boersma; Martin J Schalij; Jeroen J Bax
Journal:  J Am Coll Cardiol       Date:  2009-02-10       Impact factor: 24.094

4.  Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011).

Authors: 
Journal:  Circ J       Date:  2012-11-17       Impact factor: 2.993

5.  Do baseline diastolic echocardiographic parameters predict outcome after resynchronization therapy? Results from the PROSPECT trial.

Authors:  Renee M Sullivan; Jaime Murillo; Bart Gerritse; Eugene Chung; Michael V Orlov; Berthold Stegemann; Michelle Fedewa; Brett J Peterson; Jing Ping Sun; Brian Olshansky
Journal:  Pacing Clin Electrophysiol       Date:  2012-11-04       Impact factor: 1.976

6.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

7.  Different Methods to Measure QRS Duration in CRT Patients: Impact on the Predictive Value of QRS Duration Parameters.

Authors:  Jan De Pooter; Milad El Haddad; Liesbeth Timmers; Frédéric Van Heuverswyn; Luc Jordaens; Mattias Duytschaever; Roland Stroobandt
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-09-22       Impact factor: 1.468

8.  The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.

Authors:  Michael R Gold; Claude Daubert; William T Abraham; Stefano Ghio; Martin St John Sutton; John Harrison Hudnall; Jeffrey Cerkvenik; Cecilia Linde
Journal:  Heart Rhythm       Date:  2014-11-15       Impact factor: 6.343

9.  The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy.

Authors:  David D Daly; Anbukarasi Maran; J Madison Hyer; Frederick Funke; Ashley Waring; Frank A Cuoco; J Lacy Sturdivant; Robert B Leman; Michael R Gold
Journal:  Pacing Clin Electrophysiol       Date:  2016-06-07       Impact factor: 1.976

10.  Correlation of mechanical dyssynchrony with QRS duration measured by signal-averaged electrocardiography.

Authors:  George K Andrikopoulos; Stylianos Tzeis; Christof Kolb; Dimitrios Sakellariou; Dimosthenes Avramides; Evangelos C Alexopoulos; Konstantinos Triantafyllou; Antonis S Manolis
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-07       Impact factor: 1.468

View more
  1 in total

1.  Association of QT dispersion with mortality and arrhythmic events-A meta-analysis of observational studies.

Authors:  George Bazoukis; Cynthia Yeung; Ryan Wui Hang Ho; Dimitrios Varrias; Stamatis Papadatos; Sharen Lee; Ka Ho Christien Li; Antigoni Sakellaropoulou; Athanasios Saplaouras; Panagiotis Kitsoulis; Konstantinos Vlachos; Konstantinos Lampropoulos; Costas Thomopoulos; Konstantinos P Letsas; Tong Liu; Gary Tse
Journal:  J Arrhythm       Date:  2019-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.